Microscale culture of human liver cells for drug development
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Tissue function depends on hierarchical structures extending from single cells ( approximately 10 microm) to functional subunits (100 microm-1 mm) that coordinate organ functions. Conventional cell culture disperses tissues into single cells while neglecting higher-order processes. The application of semiconductor-driven microtechnology in the biomedical arena now allows fabrication of microscale tissue subunits that may be functionally improved and have the advantages of miniaturization. Here we present a miniaturized, multiwell culture system for human liver cells with optimized microscale architecture that maintains phenotypic functions for several weeks. The need for such models is underscored by the high rate of pre-launch and post-market attrition of pharmaceuticals due to liver toxicity. We demonstrate utility through assessment of gene expression profiles, phase I/II metabolism, canalicular transport, secretion of liver-specific products and susceptibility to hepatotoxins. The combination of microtechnology and tissue engineering may enable development of integrated tissue models in the so-called 'human on a chip'.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, hepatic models that utilize conventional 2D mono-and co-cultures of normal and diseased human cells fail to mimic the complex threedimensional (3D) in vivo microenvironment and extracellular matrix (ECM) support [16,19,20].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [16]
In the citing paper
“The oxygenated or microfabricated co-cultures have been reported to allow HHs to retain metabolic function for a few weeks; however, these cells lose their proliferative capacity (Khetani and Bhatia, 2008; Kidambi et al., 2009”
From In Vitro Expansion of Primary Human Hepatocytes with Efficient Liver Repopulation Capacity (2018) · cites this paper as Khetani and Bhatia, 2008
Citations
Cites
Geometric Control of Cell Life and Death
Chen, C. S., Mrksich, M., Huang, S., Whitesides, G. M., & Ingber, D. E. (1997) · Science · doi:10.1126/science.276.5317.1425 · Cited by 4,657 · cited 1×
“Over the last decade, microtechnology tools have emerged to probe biomedical phenomena at relevant length scales and to miniaturize and parallelize biomedical assay”
BackgroundRheinwatd, J. G., & Green, H. (1975) · Cell · doi:10.1016/s0092-8674(75)80001-8 · Cited by 4,537
Soft Lithography in Biology and Biochemistry
Whitesides, G. M., Ostuni, E., Takayama, S., Jiang, X., & Ingber, D. E. (2001) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.3.1.335 · Cited by 2,607 · cited 1×
“Our approach incorporates 'soft lithography' techniques, using reusable, elastomeric molds of microfabricated structures to overcome limitations of photolithograph”
MethodIdiosyncratic drug hepatotoxicity
Kaplowitz, N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1750 · Cited by 1,054 · cited 1×
“The need for such models is underscored by the high rate of pre-launch and post-market attrition of pharmaceuticals due to liver toxicit”
BackgroundGenome-wide expression monitoring in Saccharomyces cerevisiae
Wodicka, L., Dong, H., Mittmann, M., Ho, M.-H., & Lockhart, D. J. (1997) · Nature Biotechnology · doi:10.1038/nbt1297-1359 · Cited by 973
Bhatia, S. N., Balis, U. J., Yarmush, M. L., & Toner, M. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.14.1883 · Cited by 890
Self-citationWilkening, S., Stahl, F., & Bader, A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.8.1035 · Cited by 794 · cited 1×
“Although hepatocarcinoma-derived cell lines and immortalized hepatocytes can be reproducible and inexpensive, they display abnormal levels of liver-specific function”
BackgroundHewitt, N. J., Gómez Lechón, M. J., Houston, J. B., Hallifax, D., Brown, H. S., Maurel, P., Kenna, J. G., Gustavsson, L., Lohmann, C., Skonberg, C., et al. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530601093489 · Cited by 735
Newton, D. J., Wang, R. W., & Lu, A. Y. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06500-6 · Cited by 605
LeCluyse, E. L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00135-x · Cited by 477
Cited by
Items 501–600 of 1,000
Hong, S., & Song, J. M. (2021) · Biomaterials Science · doi:10.1039/d1bm00749a · Cited by 39
Galloway, S. M. (2017) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22077 · Cited by 39
Mohajeri, M., Eskandari, M., Ghazali, Z. S., & Ghazali, H. S. (2022) · Biomedical Physics & Engineering Express · doi:10.1088/2057-1976/ac4e2d · Cited by 39
Ladeira, B., Custódio, C. A., & Mano, J. F. (2022) · Biomaterials Science · doi:10.1039/d1bm01974k · Cited by 39
He, J., Xu, F., Cao, Y. Q., Liu, Y., Li, D., & Jin, Z. (2014) · Applied Physics Letters · doi:10.1063/1.4905151 · Cited by 39
Kim, M. K., Jeong, W., Jeon, S., & Kang, H.-W. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1305023 · Cited by 38
“In this regard, several in vitro liver models for drug toxicity testing have been developed (Khetani and Bhatia, 2008; Nguyen et al., 2016; Bircsak et al., 2021; Lee et al., 2021).”
BackgroundMarch, S., Nerurkar, N., Jain, A., Andrus, L., Kim, D. M., Whittaker, C. A., Tan, E. K. W., Thiberge, S., Fleming, H. E., Mâncio-Silva, L., et al. (2024) · Science Advances · doi:10.1126/sciadv.adm9281 · Cited by 38
“Following an overnight incubation, cultures were extensively washed and mouse 3T3-J2 fibroblasts were seeded and allowed to bind in the intervening space between hepatocytes islands to stabilize the functional phenotype of the PHH ( 28 ).”
MethodSelf-citationKukla, D. A., Crampton, A. L., Wood, D. K., & Khetani, S. R. (2020) · Gene Expression · doi:10.3727/105221620x15868728381608 · Cited by 38
Self-citation3D micro-organisation printing of mammalian cells to generate biological tissues
Jeffries, G. D. M., Xu, S., Lobovkina, T., Kirejev, V., Tusseau, F., Gyllensten, C., Singh, A. K., Karila, P., Moll, L., & Orwar, O. (2020) · Scientific Reports · doi:10.1038/s41598-020-74191-w · Cited by 39
Xiao, R., Lv, T., Tu, X., Li, P., Wang, T., Dong, H., Tu, P., & Ai, X. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.27931 · Cited by 38
Kang, J. H., Um, E., & Park, J. (2009) · Journal of Micromechanics and Microengineering · doi:10.1088/0960-1317/19/4/045027 · Cited by 38
“In particular, the polymer membrane with through-holes has been usefully devoted to making multilayered microfluidic channels [3] and sieves for a cell culture [4, 5].”
BackgroundAre zebrafish larvae suitable for assessing the hepatotoxicity potential of drug candidates?
Mesens, N., Crawford, A. D., Menke, A. L., Hung, P. D., Goethem, F. V., Nuyts, R., Hansen, E., Wolterbeek, A. P. M., Gompel, J. V., de Witte, P. A. M., et al. (2015) · Journal of Applied Toxicology · doi:10.1002/jat.3091 · Cited by 37
Engineering a Cell Home for Stem Cell Homing and Accommodation
Wu, R., Yin, Y., He, X., Li, X., & Chen, F. (2017) · Advanced Biosystems · doi:10.1002/adbi.201700004 · Cited by 38
Microfluidic Cell Culture Platforms to Capture Hepatic Physiology and Complex Cellular Interactions
Bale, S. S., & Borenstein, J. T. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.083055 · Cited by 37
“…in extending the longevity of a primary hepatocyte culture include sandwich culture (Dunn et al., 1991, 1992), micropatterned cocultures (Bhatia et al., 1999; Khetani and Bhatia, 2008), 3D printing (Nguyen et al., 2016; Nguyen and Pentoney, 2017), and spheroid formation (Messner et al., 2013).”
BackgroundArez, F., Rebelo, S. P., Fontinha, D., Simão, D. F., Martins, T. R., Machado, M., Fischli, C., Oeuvray, C., Badolo, L., Carrondo, M. J. T., et al. (2019) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.9b00144 · Cited by 37
Dambach, D. M., Misner, D., Brock, M., Fullerton, A. M., Proctor, W. R., Maher, J. M., Lee, D. H., Ford, K. A., & Diaz, D. (2015) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00396 · Cited by 37
Gough, A., Vernetti, L. A., Bergenthal, L., Shun, T. Y., & Taylor, D. L. (2016) · Applied In Vitro Toxicology · doi:10.1089/aivt.2016.0011 · Cited by 37
“…with Kupffer, endothelial, and stellate cells, 21 human bone marrow mesenchymal stem cells 22 and other cells in static or perfusion cultures 23 provide clear evidence that more in vivo– like tissue models under more physiological conditions improves the health and functions of hepatocytes,…”
Peptide-based scaffolds for the culture and maintenance of primary human hepatocytes
MacPherson, D., Bram, Y., Park, J., & Schwartz, R. E. (2021) · Scientific Reports · doi:10.1038/s41598-021-86016-5 · Cited by 36
Hormone and Drug-Mediated Modulation of Glucose Metabolism in a Microscale Model of the Human Liver
Davidson, M. D., Lehrer, M., & Khetani, S. R. (2015) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2014.0512 · Cited by 34
“We chose 3T3-J2 fibroblasts as the support cell type in MPCCs because of ease of propagation, contact inhibition of growth in culture, lack of detectable liver functions, and induction of liver phenotype in hepatocytes from multiple species.(22,44) Nonetheless, our preliminary studies indicate that the fibroblast mono…”
InfluentialSelf-citationCellular therapy and bioartificial approaches to liver replacement
Wertheim, J. A., Baptista, P. M., & Soto–Gutiérrez, A. (2012) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283534ec9 · Cited by 36
“Similarly, seeding of hepatocytes in micropatterned surfaces along with stromal cells enhances hepatocyte function, allowing tissue engineered constructs to retain high rates of specific hepatic metabolic function [21].”
BackgroundFloren, M. L., & Tan, W. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.04.036 · Cited by 36
Bioprinting of Organ-on-Chip Systems: A Literature Review from a Manufacturing Perspective
Thakare, K., Jerpseth, L., Pei, Z., Elwany, A. H., Quek, F. K. H., & Qin, H. (2021) · Journal of Manufacturing and Materials Processing · doi:10.3390/jmmp5030091 · Cited by 36
“Currently, most of the reported studies either focus on demonstrating the application of developing novel bioprinting strategies for fabricating functional organ-on-chip systems [53,57,66,74,79,80] or provide proof-ofconcept applications of using organ-on-chip systems fabricated with bioprinting for drug screening [54…”
BackgroundTelles-Silva, K. A., Pacheco, L. V. B., Komatsu, S., Chianca, F., de Caires-Junior, L. C., Araújo, B. H. S., Goulart, E., & Zatz, M. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.845360 · Cited by 36
“Liver-on-a-chip devices can incorporate liver organoids and other technologies to better recapitulate liver diseases and drug response (Khetani and Bhatia, 2008).”
BackgroundLiver-on-a-chip: Considerations, advances, and beyond
Yang, Z., Liu, X., Cribbin, E. M., Kim, A. M., Li, J. J., & Yong, K. (2022) · Biomicrofluidics · doi:10.1063/5.0106855 · Cited by 36
Yan, S., Wei, J., Liu, Y., Zhang, H., Chen, J., & Li, X. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.09.027 · Cited by 36
Lillegard, J. B., Fisher, J. E., Nedredal, G. I., Luebke-Wheeler, J. L., Bao, J., Wang, W., Amoit, B., & Nyberg, S. L. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22651 · Cited by 36
“Primary hepatocytes are also essential to pharmaceutical companies for metabolism and safety studies of new drugs (Johnson and Wolfgang, 2000; Khetani and Bhatia, 2008).”
BackgroundDirected cell attachment by tropoelastin on masked plasma immersion ion implantation treated PTFE
Bax, D. V., McKenzie, D. R., Bilek, M., & Weiss, A. S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.060 · Cited by 36
Drăgan, C.-A., Buchheit, D., Bischoff, D., Ebner, T., & Bureik, M. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.030965 · Cited by 36
“enzyme preparations obtained after recombinant expression of metabolizing enzymes in cell culture or microbial systems (Radominska-Pandya et al., 2005; Khetani and Bhatia, 2008).”
BackgroundSchaefer, M., Schänzle, G., Bischoff, D., & Süßmuth, R. D. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.067348 · Cited by 36
“More recently, microfluidic (Novik et al., 2010) and static micropatterned hepatocyte coculture models (Khetani and Bhatia, 2008) have been described as advanced tools for long-term applications (Wang et al., 2010) and shown to be suitable for CL prediction (Chan et al., 2013).”
MethodScalable Spheroid Model of Human Hepatocytes for Hepatitis C Infection and Replication
Ananthanarayanan, A., Nugraha, B., Triyatni, M., Hart, S., Suryanarayana, S., & Yu, H. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500063y · Cited by 36
Paper supported long-term 3D liver co-culture model for the assessment of hepatotoxic drugs
Wang, Y., Su, W., Wang, L., Jiang, L., Liu, Y., Hui, L., & Qin, J. (2018) · Toxicology Research · doi:10.1039/c7tx00209b · Cited by 36
Translating scientific discovery: the need for preclinical models of nonalcoholic steatohepatitis
Oseini, A. M., Cole, B. K., Issa, D., Feaver, R. E., & Sanyal, A. J. (2018) · Hepatology International · doi:10.1007/s12072-017-9838-6 · Cited by 36
In Vitro Systems for the Study of Hepatitis C Virus Infection
Wilson, G. K., & Stamataki, Z. (2012) · International Journal of Hepatology · doi:10.1155/2012/292591 · Cited by 35
“More recently key aspects of the HCV lifecycle have been delineated in primary hepatocytes, including pH-dependent virus entry using the HCV pseudoparticle system (HCVpp) and clathrin-mediated endocytosis [37, 38].”
MethodAdvances and Challenges in Studying Hepatitis B Virus In Vitro
Witt-Kehati, D., Alaluf, M. B., & Shlomai, A. (2016) · Viruses · doi:10.3390/v8010021 · Cited by 35
“Realizing that the in vitro maintenance of phenotypically stable primary human hepatocytes over time is a major goal not only for studying hepatotropic viruses, but also for the purpose of drug screenings as well as for metabolic and toxicity studies [9], Bhatia’s lab has integrated tissue engineering with micro techn…”
BackgroundYucha, R. W., He, K., Shi, Q., Cai, L., Nakashita, Y., Xia, C. Q., & Liao, M. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx060 · Cited by 35
“…þ stromal cell cocultures, and 3D liver organoids have been utilized to assess BA efflux inhibition and corresponding DILI (Gunness et al., 2013; Khetani and Bhatia, 2008; Khetani et al., 2013; Lee et al., 2013; Novik et al., 2010; Trask et al., 2014; Xu et al., 2008; Zhang et al., 2016).”
BackgroundMethodInfluentialKim, J., Lee, H., Selimović, Š., Gauvin, R., & Bae, H. (2015) · Drug Safety · doi:10.1007/s40264-015-0284-x · Cited by 34
Lu, J., Zhang, X., Li, J., Yu, L., Chen, E., Zhu, D., Zhang, Y., & Li, L. (2016) · PLOS ONE · doi:10.1371/journal.pone.0147376 · Cited by 32
“Several classes of CYP450 phase I and phase II enzymes and specific proteins [22] were selected to test whether the DMFBB could improve the transcription of metabolism-related genes in hepatocytes by real-time PCR (Fig 6).”
MethodEntry and passage behavior of biological cells in a constricted compliant microchannel
Raj, A., & Sen, A. K. (2018) · RSC Advances · doi:10.1039/c8ra02763c · Cited by 34
Tissue Chips and Microphysiological Systems for Disease Modeling and Drug Testing
Donoghue, L., Nguyen, K. T. V., Graham, C., & Sethu, P. (2021) · Micromachines · doi:10.3390/mi12020139 · Cited by 34
“While faithful recreation of lobular architecture may require complex patterning procedures, more straightforward patterning methodologies can still lead to impressive results, as demonstrated by Khetani and Bhatia’s 2D micropatterned co-culture model (MPCC), which they developed in 2008 [106].”
BackgroundZhang, C., & van Noort, D. (2011) · Topics in current chemistry · doi:10.1007/128_2011_147 · Cited by 34
Toyoda, Y., Tamai, M., Kashikura, K., Kobayashi, S., Fujiyama, Y., Soga, T., & Tagawa, Y. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.041137 · Cited by 35
“, micropatterning (El-Ali et al., 2006; Khetani and Bhatia, 2008), shear stress (Vinci et al.”
BackgroundKnöspel, F., Jacobs, F., Freyer, N., Damm, G., Bondt, A. D., den Wyngaert, I. V., Snoeys, J., Monshouwer, M., Richter, M., Strahl, N., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040584 · Cited by 34
“To overcome the limitations of classical 2D culture systems, various 2D co-culture and 3D culture systems for cultivation of pHH were developed to improve the long-term maintenance and functionality of the cells in vitro [9–11].”
MethodHughes, D. J., Kostrzewski, T., & Sceats, E. L. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217708976 · Cited by 31
Translating advances in organ‐on‐a‐chip technology for supporting organs
Ashammakhi, N. A., ELKHAMMAS, E. A., & Hasan, A. (2018) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.34292 · Cited by 34
Jiang, J., Pieterman, C., Ertaylan, G., Peeters, R., & de Kok, T. M. C. M. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02585-5 · Cited by 34
Terelius, Y., Figler, R. A., Marukian, S., Collado, M. S., Lawson, M. J., Mackey, A. J., Manka, D., Qualls, C. W., Blackman, B. R., Wamhoff, B. R., et al. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.11.023 · Cited by 33
“The differentiated state results in restoration of liver-like responsiveness that allows us to culture the cells at near-physiological levels of glucose and insulin(24), unlike other culture systems that need up to 20,000 times higher levels of insulin in the culture media(25, 26).”
BackgroundLiver microsystems in vitro for drug response
Lee, J.-H., Ho, K.-L., & Fan, S.-K. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0575-0 · Cited by 33
Multiscale tissue engineering for liver reconstruction
Sudo, R. (2014) · Organogenesis · doi:10.4161/org.27968 · Cited by 32
Reusable biocatalytic crosslinked microparticles self-assembled from enzyme-nanoparticle complexes
Jeong, Y., Duncan, B., Park, M., Kim, C., & Rotello, V. M. (2011) · Chemical Communications · doi:10.1039/c1cc14448k · Cited by 33
Stine, M. J., Wang, C. J., Moriarty, W. F., Ryu, B., Cheong, R., Westra, W. H., Levchenko, A., & Alani, R. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1875 · Cited by 33
“Intercellular signaling has been studied by patterning cell pairs (12) or heterotypic cell populations, using a variety of techniques, including micro-stencils, microcontact cell printing, dielectrophoretic cell capture and reconfigurable micromechanic manipulation (13-15).”
Shologu, N., Szegezdi, É., Lowery, A., Kerin, M. J., Pandit, A. S., & Zeugolis, D. I. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.06.001 · Cited by 33
Additive Manufacturing of Biomedical Constructs with Biomimetic Structural Organizations
Li, X., He, J., Zhang, W., Jiang, N., & Li, D. (2016) · Materials · doi:10.3390/ma9110909 · Cited by 33
“For instance, hepatocytes would rapidly lose their functions once isolated from their native multicellular environment [84,85].”
BackgroundAntifouling Stripes Prepared from Clickable Zwitterionic Copolymers
Sae‐ung, P., Kolewe, K. W., Bai, Y., Rice, E. W., Schiffman, J. D., Emrick, T. S., & Hoven, V. P. (2017) · Langmuir · doi:10.1021/acs.langmuir.7b01431 · Cited by 33
A simple approach for restoration of differentiation and function in cryopreserved human hepatocytes
Ölander, M., Wiśniewski, J. R., Flörkemeier, I., Handin, N., Urdzik, J., & Artursson, P. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2375-9 · Cited by 33
Long-term culture of human liver tissue with advanced hepatic functions
Ng, S. S., Xiong, A., Nguyen, K., Masek, M., No, D. Y., Elazar, M., Shteyer, E., Winters, M. A., Voedisch, A., Shaw, K., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.90853 · Cited by 32
“Over the last decade, certain success has been achieved by spatially controlled plating of hepatocytes with nonparenchymal cells using microtechnology-based processes, although these remain largely 2-dimensional (2D) in nature with limited scale-up potential for cell-based therapies (6, 7).”
BackgroundNajjaran, S., Rashidi, S., & Valipour, M. S. (2020) · International Communications in Heat and Mass Transfer · doi:10.1016/j.icheatmasstransfer.2020.104564 · Cited by 32
Evaluation of an in vitro toxicogenetic mouse model for hepatotoxicity
Martinez, S. M., Bradford, B. U., Soldatow, V. Y., Kosyk, O., Sandot, A., Witek, R. P., Kaiser, R. A., Stewart, T. W., Amaral, K. B., Freeman, K., et al. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.09.012 · Cited by 32
“These include co-culture with other liver-derived or non-liver cell types, exposing hepatocytes to a gel substratum, culture in collagen gel sandwiches, and culture in spheroids and in 3D bioreactors (LeCluyse, 2001a; Sivaraman et al., 2005; Khetani and Bhatia, 2008; Godoy et al., 2009).”
InfluentialLi, Y., Zhou, J., Ramsden, D., Taub, M. E., O'Brien, D., Xu, J., Busacca, C. A., Gonnella, N. C., & Tweedie, D. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.055863 · Cited by 33
“The HepatoPac model from a female Caucasian donor was prepared by Hepregen Corporation as described previously (Khetani and Bhatia, 2008).”
MethodHashimoto, M., Tong, R., & Kohane, D. S. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300652m · Cited by 32
Yao, R., Wang, J., Li, X., Jung Jung, D., Qi, H., Kee, K. K., & Du, Y. (2014) · Small · doi:10.1002/smll.201401040 · Cited by 27
In Vitro Intestinal and Liver Models for Toxicity Testing
Orbach, S. M., Less, R. R., Kothari, A., & Rajagopalan, P. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00699 · Cited by 31
New Tools and New Biology: Recent Miniaturized Systems for Molecular and Cellular Biology
Hamon, M., & Hong, J. W. (2013) · Molecules and Cells · doi:10.1007/s10059-013-0333-1 · Cited by 31
Riches, Z., Bloomer, J. C., Patel, A. H., Nolan, A., & Coughtrie, M. W. H. (2009) · Xenobiotica · doi:10.1080/00498250902763440 · Cited by 31
“Recent advances in applying cultured hepatocytes in microscale, high throughput format (Khetani & Bhatia 2008) suggest that they will become increasingly valuable in the drug development process.”
BackgroundOn-chip culturing of hepatocytes and monitoring their ammoniametabolism
Satoh, W., Takahashi, S., Sassa, F., Fukuda, J., & Suzuki, H. R. (2008) · Lab on a Chip · doi:10.1039/b810961c · Cited by 31
Towards a Humanized Mouse Model of Liver Stage Malaria Using Ectopic Artificial Livers
Ng, S., March, S., Galstian, A., Gural, N., Stevens, K. R., Mota, M. M., & Bhatia, S. N. (2017) · Scientific Reports · doi:10.1038/srep45424 · Cited by 31
Self-citationNguyen, T., Phan, H., Kamble, H., Vadivelu, R. K., Dinh, T., Iacopi, A., Walker, G., Hold, L., Nguyen, N., & Dao, D. V. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b15381 · Cited by 31
Humanized Mice and the Rebirth of Malaria Genetic Crosses
Vendrely, K. M., Kumar, S., Li, X., & Vaughan, A. M. (2020) · Trends in Parasitology · doi:10.1016/j.pt.2020.07.009 · Cited by 31
“Additionally, the development of microscale human liver platforms that combine primary human hepatocytes with supportive stromal cells have been described [72, 73] and can support infection with P.”
BackgroundDocci, L., Klammers, F., Ekiciler, A., Molitor, B., Umehara, K., Walter, I., Krähenbühl, S., Parrott, N. J., & Fowler, S. M. (2020) · The AAPS Journal · doi:10.1208/s12248-020-00482-9 · Cited by 31
“The surface of HepatoPac cultures consist of 25% hepatocytes and 75% mouse fibroblasts (10).”
BackgroundHu, W., Wang, Y., Han, J., Zhang, W., Chen, J., Li, X., & Wang, L. (2025) · Biomaterials Science · doi:10.1039/d4bm01273a · Cited by 30
Raasch, M., Fritsche, E., Kurtz, A., Bauer, M., & Mosig, A. S. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.06.008 · Cited by 29
Emerging trends in modeling human liver disease in vitro
Underhill, G. H., & Khetani, S. R. (2019) · APL Bioengineering · doi:10.1063/1.5119090 · Cited by 30
Self-citationMatsuzawa, A., Matsusaki, M., & Akashi, M. (2014) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35292 · Cited by 30
Mimicking the biological world: Methods for the 3 D structuring of artificial cellular environments
Schober, A., Fernekorn, U., Singh, S., Schlingloff, G., Gebinoga, M., Hampl, J., & Williamson, A. (2013) · Engineering in Life Sciences · doi:10.1002/elsc.201200088 · Cited by 30
“Although current approaches in 3D cell culturing have not reached the level of standard applications, it is widely accepted that miniaturized bioreactors better reflect in vivo environments as they can more accurately represent diffusion gradients across tissues and cellular interactions [64].”
BackgroundRamsden, D., Tweedie, D., George, R. S., Chen, L., & Li, Y. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.055947 · Cited by 30
“The rat HepatoPac model was prepared using cryoplateable rat hepatocytes as described previously (Khetani and Bhatia, 2008).”
MethodLab on a chip-based hepatic sinusoidal system simulator for optimal primary hepatocyte culture
Choi, Y. Y., Kim, J., Lee, S., & Kim, D. (2016) · Biomedical Microdevices · doi:10.1007/s10544-016-0079-6 · Cited by 30
Tokuda, E. Y., Jones, C. E., & Anseth, K. S. (2017) · Integrative Biology · doi:10.1039/c6ib00229c · Cited by 29
Microelectrofluidic probe for sequential cell separation and patterning
Brimmo, A. T., Menachery, A., & Qasaimeh, M. A. (2019) · Lab on a Chip · doi:10.1039/c9lc00748b · Cited by 30
Assembly of Human Organs from Stem Cells to Study Liver Disease
Handa, K., Matsubara, K., Fukumitsu, K., Guzman‐Lepe, J., Watson, A. R., & Soto–Gutiérrez, A. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.11.003 · Cited by 30
“Organ-like systems have already been shown to be integral for the study of the cellular microenvironment, particularly responses to the perturbation of the microenvironment in pathological situations, as well as hepatic differentiation of stem cells.(8,9,11,16,17) Organ-like systems based on human cells may bridge the…”
BackgroundMohutsky, M. A., Romeike, A., Meador, V., Lee, W. M., Fowler, J., & Francke‐Carroll, S. (2010) · Toxicologic Pathology · doi:10.1177/0192623310375099 · Cited by 30
Hepatitis C Virus and Hepatocellular Carcinoma
Lindenbach, B. D. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0016-5_23 · Cited by 30
Biomaterials for neuroengineering: applications and challenges
Wu, H., Feng, E., Yin, H., Zhang, Y., Chen, G., Zhu, B., Yue, X., Zhang, H., Liu, Q., & Xiong, L. (2025) · Regenerative Biomaterials · doi:10.1093/rb/rbae137 · Cited by 29
“The phase guide technique, widely utilized in commercial organ-on-a-chip platforms, exemplified by the OrganoPlate ® from Mimetas Company, involves the injection of a hydrogel into one channel of an inter-connected multichannel device [183, 184].”
Substrate Mediated Enzyme Prodrug Therapy
Fejerskov, B., & Zelikin, A. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049619 · Cited by 29
“Inasmuch as liver failure is among the leading causes of death worldwide, hepatic tissue engineering [30] attracts increased research attention and Figure 1.”
BackgroundThomas, C. E., & Will, Y. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.651122 · Cited by 29
“Recently, a micropatterned coculture model (HepatoPac) was developed that can be used for up to 6 weeks in culture [62].”
MethodBarriers of hepatitis C virus interspecies transmission
Sandmann, L., & Ploß, A. (2012) · Virology · doi:10.1016/j.virol.2012.09.044 · Cited by 29
“However, even in the most advanced tissue culture platforms, including micropatterned primary hepatocyte co-cultures (MPCCs; Jones et al., 2010a; Khetani and Bhatia, 2008; Ploss et al., 2010) , cultures of human fetal hepatocytes Marukian et al., 2011) , or hepatocyte-like cells derived from induced pluripotentstem ce…”
Label-Free Segmentation of Co-cultured Cells on a Nanotopographical Gradient
Reynolds, P. M., Pedersen, R. H., Stormonth-Darling, J., Dalby, M. J., Riehle, M. O., & Gadegaard, N. (2012) · Nano Letters · doi:10.1021/nl304097p · Cited by 29
New Methods in Tissue Engineering: Improved Models for Viral Infection
Ramanan, V., Scull, M. A., Sheahan, T. P., Rice, C. M., & Bhatia, S. N. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085437 · Cited by 29
“MPCCs are used at an industrial scale for screening drugs for human liver toxicity (57, 197), and AggreWell plates can reliably produce defined-size cellular aggregates for stem cell culture and TE (198).”
Self-citationAnti-Cancer Drug Screening Based on a Adipose-Derived Stem Cell/Hepatocyte 3D Printing Technique
Du, X. Z. S. (2015) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000273 · Cited by 29
Moore, A., Chothe, P. P., Tsao, H., & Hariparsad, N. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.072660 · Cited by 29
“This extensive recovery period allows the hepatocytes to regain their polarity and form a biliary network that is essential for proper functioning of canalicular and sinusoidal transporters (Khetani and Bhatia, 2008).”
BackgroundZhang, B.-B., Li, Y., Wang, G., Jia, Z., Li, H., Peng, Q., & Gao, Y. (2018) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-018-6058-0 · Cited by 29
Multi-organ on a chip for personalized precision medicine
Palaninathan, V., Kumar, V., Maekawa, T., Liepmann, D., Paulmurugan, R., Eswara, J. R., Ajayan, P. M., Augustine, S., Malhotra, B. D., Viswanathan, S., et al. (2018) · MRS Communications · doi:10.1557/mrc.2018.148 · Cited by 29
Kang, W., Podtelezhnikov, A. A., Tanis, K. Q., Pacchione, S. J., Su, M., Bleicher, K. B., Wang, Z., Laws, G. M., Griffiths, T. G., Kuhls, M. C., et al. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa094 · Cited by 29
Investigating acetaminophen hepatotoxicity in multi-cellular organotypic liver models
Orbach, S. M., Cassin, M. E., Ehrich, M. F., & Rajagopalan, P. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.03.008 · Cited by 28
Klaas, M., Möll, K., Mäemets‐Allas, K., Loog, M., Järvekülg, M., & Jaks, V. (2021) · Scientific Reports · doi:10.1038/s41598-021-99659-1 · Cited by 28
Takahashi, S., Yamazoe, H., Sassa, F., Suzuki, H. R., & Fukuda, J. (2009) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2009.06.013 · Cited by 28
HCV Infection by Cell-to-Cell Transmission: Choice or Necessity?
Carloni, G., Crema, A., Valli, M. B., Ponzetto, A., & Clementi, M. (2011) · Current Molecular Medicine · doi:10.2174/156652412798376152 · Cited by 28
“It is unclear whether or not some of the macroscale and microscale cellular systems reported to preserve in vitro specific structural and functional liver functions, really sustain long-term production of abundant infectious virus or not [27-29].”
BackgroundTrevisan, M., Sinigaglia, A., Desole, G., Berto, A., Pacenti, M., Palù, G., & Barzon, L. (2015) · Viruses · doi:10.3390/v7072800 · Cited by 28
“Co-culture of primary hepatocytes with supportive stromal cells has allowed prolonging hepatocyte viability and their differentiated phenotype [61,62].”
Human Pluripotent Stem Cells for Modeling Toxicity
Sison-Young, R. L. C., Kia, R., Heslop, J. A., Kelly, L., Rowe, C., Cross, M. J., Kitteringham, N. R., Hanley, N. A., Park, B. K., & Goldring, C. E. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-398339-8.00006-9 · Cited by 28
Sarkar, J., & Kumar, A. (2016) · The Analyst · doi:10.1039/c6an00356g · Cited by 28
Adhesive-Tape Soft Lithography for Patterning Mammalian Cells: Application to Wound-Healing Assays
Shrirao, A. B., Hussain, A., Cho, C. H., & Perez‐Castillejos, R. (2012) · BioTechniques · doi:10.2144/000113928 · Cited by 28
Acoustofluidic waveguides for localized control of acoustic wavefront in microfluidics
Bian, Y., Guo, F., Yang, S., Mao, Z., Bachman, H., Tang, S., Ren, L., Zhang, B., Gong, J., Guo, X., et al. (2017) · Microfluidics and Nanofluidics · doi:10.1007/s10404-017-1971-y · Cited by 28
“2008), regenerative medicine (Khetani and Bhatia 2008; Smith 2007), 3D bio-printing (Kolesky et al.”
Metadata
- Authors
- Khetani, S. R., & Bhatia, S. N.
- Affiliations
- Massachusetts Institute of Technology (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Bhatia, Sangeeta N
- Venue
- Nature Biotechnology
- Published
- 2007-11-18
- Volume
- 26
- Issue
- 1
- Pages
- 120-126
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2023296392
- Cited by
- 1,219
- References
- 41
- Citations by year
- 2026: 19 · 2025: 41 · 2024: 36 · 2023: 49 · 2022: 64 · 2021: 56 · 2020: 68 · 2019: 73 · 2018: 81 · 2017: 86 · 2016: 93 · 2015: 77 · 2014: 76 · 2013: 90 · 2012: 75
- FWCI
- 38.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- human liver cells, liver-on-a-chip, hepatotoxicity, drug development, phase I and II metabolism, canalicular transport, hepatocyte secretion, gene expression profiling, tissue engineering, microtechnology
- MeSH terms
- Biological Assay, Cells, Cultured, Equipment Design, Humans, Miniaturization, Drug Design, Flow Injection Analysis, Cell Culture Techniques, Equipment Failure Analysis, Hepatocytes, Microfluidic Analytical Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.